| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 285 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 148 |
| 2 | SILDENAFIL CITRATE | 85 |
| 3 | TADALAFIL | 85 |
| 4 | AMBRISENTAN | 84 |
| 5 | MACITENTAN | 77 |
| 6 | ACETAMINOPHEN | 76 |
| 7 | GABAPENTIN | 73 |
| 8 | LIDOCAINE HYDROCHLORIDE | 67 |
| 9 | 0XYGEN | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCOA BUTTER, PHENYLEPHRINE HCL | 1 | 0.0196 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 148 | 0.0168 |
| 2 | TAVABOROLE | 1 | 0.0143 |
| 3 | METHENAMINE MANDELATE | 2 | 0.0107 |
| 4 | KETAMINE HYDROCHLORIDE | 49 | 0.0095 |
| 5 | POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE | 1 | 0.0061 |
| 6 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 7 | NATALIZUMAB-SZTN | 1 | 0.0042 |
| 8 | PENICILLIN G POTASSIUM | 3 | 0.0041 |
| 9 | KETOPROFEN | 48 | 0.0036 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 286 |
| 1 | Endothelin Receptor Antagonist [EPC] | 160 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 125 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 120 |
| 4 | Osmotic Laxative [EPC] | 92 |
| 5 | Loop Diuretic [EPC] | 81 |
| 6 | Amide Local Anesthetic [EPC] | 75 |
| 7 | Antiarrhythmic [EPC] | 73 |
| 8 | Corticosteroid [EPC] | 64 |
| 9 | Human Immunoglobulin G [EPC] | 61 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 1 | Human Immunoglobulin G [EPC] | 61 | 0.0029 |
| 2 | Catechol-O-Methyltransferase Inhibitor [EPC] | 14 | 0.0028 |
| 3 | Prostacycline Vasodilator [EPC] | 286 | 0.0021 |
| 4 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 5 | Provitamin D2 Compound [EPC] | 42 | 0.0014 |
| 6 | Soluble Guanylate Cyclase Stimulator [EPC] | 40 | 0.0012 |
| 7 | Nonergot Dopamine Agonist [EPC] | 17 | 0.0011 |
| 8 | Prostacycline [EPC] | 1 | 0.0011 |
| 9 | Type I Interferon Receptor Antagonist [EPC] | 2 | 0.0010 |